Coronary thrombolysis, conjunctive heparin infusion, and the effect on systemic thrombin activity.
- 1 March 1992
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 85 (3) , 1205-1207
- https://doi.org/10.1161/01.cir.85.3.1205
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Role of new anticoagulants as adjunctive therapy during thrombolysisThe American Journal of Cardiology, 1991
- Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarctionThe American Journal of Cardiology, 1991
- Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1990
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990
- Thrombolytic Therapy in Acute Myocardial InfarctionAnnual Review of Medicine, 1989
- Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.Circulation, 1988
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.Heart, 1985
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980